HUMANIZED ANTI-C5A ANTIBODIES AND USES THEREOF

Provided is inhibition of the complement signaling using a humanized anti-C5a antibody. Provided are methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with the humanized anti-C5a antibody. L'invention concerne l'...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ZHANG, Jianjun, QI, Shigang, SONG, Wenchao, MIWA, Takashi, TSUI, Ping, GULLIPALLI, Damodara Rao, ZHU, Xihua, SATO, Sayaka
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided is inhibition of the complement signaling using a humanized anti-C5a antibody. Provided are methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with the humanized anti-C5a antibody. L'invention concerne l'inhibition de la signalisation du complément à l'aide d'un anticorps anti-C5a humanisé. L'invention concerne des méthodes de traitement d'une maladie médiée par le complément ou d'un trouble médié par le complément chez un individu par la mise en contact de l'individu avec l'anticorps anti-C5a humanisé.